_________
false
אקס טי אל ביופרמסוטיקלס בע"מ
2
380
X T L BIOPHARMACEUTICALS LTD
Corporation no:
520039470
4313
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
01/11/2018
www.isa.gov.il
www.tase.co.il
Reference:
2018-02-103437
Time of broadcast:
15:28
15:25:00
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.
Delay the publication of a report
_________
_________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Financial results for the third quarter ended September 30, 2018.
f6k110118_xtlbiopharma_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
04/09/2018
Address:
HaCharoshet st
5
,
Ra'anana
43656
Israel
,
Tel:
09-9557080
,
Fax:
09-9519708
E-mail address:
ir@xtlbio.com
Company site:
www.xtlbio.com
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Name of the Signatory:
Kntor Ronen
Position of Signatory in the reporting corporation:
Attorney/Legal Counsel
Name of Employer Company:
Address:
abba hillel
12
,
ramat gan
5250606
Telephone:
03-6133371
Facsimile:
03-6133372
E-mail:
rkantor@dtkgc.com
1